Scarica l'app Stockscreener
0.57
2.57%
-0.015
Dopo l'orario di chiusura:
.57
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$0.585
Aprire:
$0.57
Volume 24 ore:
50,954
Relative Volume:
0.03
Capitalizzazione di mercato:
$10.94M
Reddito:
$71.39M
Utile/perdita netta:
$-28.60M
Rapporto P/E:
-0.1524
EPS:
-3.74
Flusso di cassa netto:
$-12.92M
1 W Prestazione:
-14.61%
1M Prestazione:
-18.06%
6M Prestazione:
-50.86%
1 anno Prestazione:
-71.90%
Intervallo 1D:
$0.57
$0.60
Intervallo di 1 settimana:
$0.5643
$0.672
Portata 52W:
$0.5643
$3.55
Trinity Biotech Plc Adr Stock (TRIB) Company Profile
Nome
Trinity Biotech Plc Adr
Settore
Industria
Telefono
-
Indirizzo
-
Confronta TRIB con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TRIB
Trinity Biotech Plc Adr
|
0.57 | 10.94M | 71.39M | -28.60M | -12.92M | -3.74 |
|
ABT
Abbott Laboratories
|
131.63 | 228.29B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
98.50 | 145.69B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
368.15 | 142.48B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
87.89 | 112.70B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
72.98 | 42.75B | 5.72B | 4.17B | 259.90M | 6.97 |
Trinity Biotech Plc Adr Stock (TRIB) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2015-10-23 | Downgrade | Craig Hallum | Buy → Hold |
| 2015-09-03 | Iniziato | Raymond James | Outperform |
| 2015-07-29 | Reiterato | ROTH Capital | Buy |
| 2008-07-22 | Reiterato | Roth Capital | Buy |
| 2008-03-17 | Reiterato | Roth Capital | Buy |
| 2007-12-10 | Reiterato | Roth Capital | Buy |
| 2007-10-26 | Reiterato | Roth Capital | Buy |
Mostra tutto
Trinity Biotech Plc Adr Borsa (TRIB) Ultime notizie
Trinity Biotech (NASDAQ:TRIB) Research Coverage Started at StockNews.com - Armenian Reporter
Trinity Biotech stock hits 52-week low at $0.72 amid challenges By Investing.com - Investing.com South Africa
Trinity Biotech stock hits 52-week low at $0.72 amid challenges - Investing.com
Trinity Biotech secures amended credit to fuel growth By Investing.com - Investing.com South Africa
Trinity Biotech secures amended credit to fuel growth - Investing.com India
Trinity Biotech secures $4m for CGM technology growth - Investing.com
Investor Network: Trinity Biotech Plc Sponsored ADR to Host Earnings Call - ACCESS Newswire
TRIBTrinity Biotech Announces Quarter 1 Financial Results - br.ADVFN.com
Trinity Biotech Announces Quarter 2 Results Revenues of US$36.3m and Operating Profit of US$2.3m - br.ADVFN.com
Trinity Biotech Announces Quarter 4 Financial Results EPS of 17.1 Cent per Share -- an Increase of 10.3% - br.ADVFN.com
Trinity Biotech Announces Quarter 3 Results; Revenues Increase to $35.6m; Operating Profit Increases 56% - br.ADVFN.com
Trinity Biotech stock hits 52-week low at $0.74 amid market challenges - Investing.com
Trinity Biotech Announces Quarter 3 Financial Results, Acquisition of Blood Bank Screening Business and FDA Approval of HIV-2... - br.ADVFN.com
Trinity Biotech Plc ADR (TRIB) Stock: A Year of Market Movement, Down and Up - The InvestChronicle
Market Highlights: Xometry Inc (XMTR) Ends on a Low Note at 36.21 - The Dwinnex
Daily Progress: SiTime Corp (SITM) Drop -20.93, Closing at 176.32 - The Dwinnex
Trinity Biotech Plc ADR (TRIB) Shares Down Despite Recent Market Volatility - The News Heater
Trinity Biotech reports leap in CGM system accuracy - Investing.com
Trinity Biotech secures US funding for HIV tests - Investing.com
Trinity Biotech faces US aid policy impact, PPP loan scrutiny - Investing.com India
Trinity Biotech announces breakthrough in CGM technology - Investing.com India
Trinity Biotech stock hits 52-week low at $0.74 amid challenges By Investing.com - Investing.com South Africa
European Equities Traded in the US as American Depositary Receipts Lower in Wednesday Trading - MSN
Hemoglobin A1c (HbA1c) Testing Market Projected to Reach $1.83 Billion by 2024, Growth Fueled by Rising Prevalence of Diabetes - GlobeNewswire Inc.
Trinity Biotech revises credit terms to boost liquidity - Investing.com India
Trinity Biotech Announces Amended Credit Agreement with Perceptive to Enhance Liquidity and Drive Transformation Plan - GlobeNewswire Inc.
Trinity Biotech advances HIV test manufacturing to offshore site - Investing.com
Trinity Biotech files to sell 0.65M American Depositary shares by selling shareholders - MSN
Earnings call: Trinity Biotech Q3 2024 shows steady growth, strategic moves - Investing.com
What to look for when Lowe’s (LOW) reports Q3 2024 earnings results - AlphaStreet
Trinity Biotech regains Nasdaq compliance - Investing.com India
Trinity Biotech expands into oncology with EpiCapture buyout - Investing.com
Trinity Biotech invests in rapid sepsis diagnostics firm By Investing.com - Investing.com
Trinity Biotech advances next-gen glucose monitor - Investing.com
Trinity Biotech Plc Adr Azioni (TRIB) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.71%
0.14%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):